GHRP-2 (Pralmorelin) 5mg / 10mg

GHRP 2 For Sale — Proven Ghrelin Receptor GH Research Peptide

GHRP 2 for sale in research-grade form — also known as pralmorelin — is a synthetic peptide analogous to the endogenous neurotransmitter met-enkephalin, yet without met-enkephalin’s opioid activity. Instead of engaging opioid receptors, GHRP-2 activates the receptors for the hormone ghrelin — the GHS-R (Growth Hormone Secretagogue Receptors) — to stimulate GH secretion from the anterior pituitary. Available in both 5mg and 10mg formats at >99% purity, this compound is formulated to the exacting standards required for in-vitro scientific research.

⚠️ Research Use Only. This product is intended exclusively for in-vitro scientific research. It is not approved for human or animal consumption, clinical use, or therapeutic application.

Table of Contents

1. Product Specifications
2. Met-Enkephalin Analogue — Without Opioid Activity
3. Ghrelin Receptor Agonism Mechanism
4. GH Secretagogue Research Profile
5. Research Applications
6. Reconstitution and Storage
7. FAQ

Product Specifications

Met-Enkephalin Analogue — Without Opioid Activity

GHRP-2 is structurally analogous to met-enkephalin — the endogenous opioid neurotransmitter. This structural relationship might suggest that GHRP-2 would share met-enkephalin’s opioid receptor activity. However, research has established that GHRP-2 appears to lack the opioid activity generally associated with enkephalins — despite its structural similarity to this opioid peptide class.

Instead of engaging μ, δ or κ opioid receptors, buy ghrp 2 research compounds activate ghrelin receptors — the GHS-R1a receptors in the hypothalamus and pituitary gland that govern GH secretion and appetite regulation. This mechanistic divergence from its structural template makes GHRP-2 a research compound of particular interest for mechanistic studies examining structure-activity relationships in the GHRP peptide class.

Ghrelin Receptor Agonism Mechanism

Ghrp-2 for sale exerts its primary research activity through activation of GHS-R1a — the ghrelin receptor — in the pituitary gland. Ghrelin is a naturally occurring 28-amino-acid peptide produced primarily by the stomach, considered to regulate food intake and energy homeostasis while simultaneously stimulating GH secretion from the anterior pituitary.

GHRP-2’s activation of GHS-R1a mimics ghrelin’s receptor-mediated activity through a synthetic peptide with distinct structural characteristics. The ghrelin receptor signalling initiated by GHRP-2 engagement activates intracellular calcium mobilisation through the IP3 pathway — ultimately triggering GH synthesis and secretion from pituitary somatotrophs.

The hypothalamic distribution of ghrelin receptors — alongside their pituitary location — means GHRP-2’s GH-stimulating activity may involve both direct pituitary somatotroph activation and indirect hypothalamic pathway modulation, providing a dual-site mechanism for GH secretagogue activity.

GH Secretagogue Research Profile

The ghrp-2 10mg and 5mg research profile covers the downstream effects of GH secretion stimulated by GHS-R1a agonism — including IGF-1 axis elevation, anabolic signalling in muscle and bone tissue, metabolic rate modulation and the appetite-stimulating effects that are characteristic of the ghrelin receptor pathway.

GHRP-2’s appetite-stimulating activity — mediated through hypothalamic GHS-R1a engagement — is a research dimension that distinguishes it from the more selective GHS-R1a agonist ipamorelin. Research examining the comparative appetite and energy homeostasis effects of different GHS-R1a agonists frequently includes GHRP-2 as a reference compound given its well-characterised profile in this context.

The purchase ghrp 2 research interest has also extended to the compound’s ACTH and cortisol elevation — effects documented at GH-stimulating concentrations — which while representing a limitation in certain research contexts also provide a research tool for investigating the relationships between GH secretagogue activity and adrenal axis responsiveness.

Research Applications

GHRP-2 is investigated within the following approved in-vitro research domains:

• GHS-R1a ghrelin receptor binding and activation studies
• GH secretion and pituitary somatotroph biology research
• Met-enkephalin analogue structure-activity relationship studies
• Appetite regulation and hypothalamic ghrelin receptor research
• IGF-1 axis modulation downstream of GH stimulation
• ACTH and cortisol elevation characterisation research
• Metabolic rate and energy homeostasis investigation
• Muscle tissue anabolic signalling research
• Sleep architecture and GH pulse correlation studies

Reconstitution and Storage

Reconstitute with sterile or bacteriostatic water at 1ml per vial. Add solvent slowly and allow to dissolve by gentle rotation. Do not shake or vortex. Store lyophilised powder at −20°C. Once reconstituted, maintain at 4°C and use within the timeframe specified by your research protocol. Protect from light and avoid repeated freeze-thaw cycles.

Explore additional GH secretagogue and growth-related research peptides in our Muscle Growth, Anti-Age and Sleep Enhancement research categories.

FAQ

What is GHRP 2 for sale? GHRP 2 for sale — also known as pralmorelin — is a synthetic peptide analogous to met-enkephalin that activates ghrelin receptors (GHS-R1a) rather than opioid receptors. It stimulates GH secretion from the anterior pituitary through ghrelin receptor agonism alongside appetite-stimulating hypothalamic activity. Available in 5mg and 10mg lyophilised formats at >99% purity for in-vitro scientific research. Not approved for human administration.

Where can I buy GHRP 2 for research? Buy GHRP 2 options are available through specialist research peptide suppliers. This compound is supplied strictly for in-vitro scientific research. It is not approved for human consumption, therapeutic use or clinical application. Researchers should ensure compliance with all applicable institutional and regulatory requirements.

What is pralmorelin buy in research contexts? Pralmorelin buy refers to sourcing the INN (International Nonproprietary Name) designated form of GHRP-2 for research purposes. Pralmorelin and GHRP-2 refer to the same compound — a synthetic GHS-R1a agonist researched for GH secretagogue activity, appetite regulation and associated metabolic biology. Available in 5mg and 10mg research formats.

How does GHRP-2 differ from ipamorelin as GHS-R1a agonists? Both GHRP-2 and ipamorelin activate GHS-R1a to stimulate GH secretion, but with distinct pharmacological profiles. GHRP-2 produces ACTH and cortisol elevation alongside GH stimulation and has a stronger appetite-stimulating effect through hypothalamic ghrelin receptor engagement. Ipamorelin is the more selective GHS-R1a agonist — not producing significant ACTH or cortisol elevation at GH-stimulating doses. The choice between them depends on whether adrenal axis confounding is a relevant variable in the research protocol.

What is GHRP-2 10mg used for in research vs the 5mg format? The GHRP-2 10mg format provides a larger research supply appropriate for extended programmes, multiple experimental series or studies requiring consistent batch material across numerous timepoints. The 5mg format is appropriate for initial research investigation or lower-volume assay requirements. Both formats carry >99% purity specification and identical compound quality — the format choice depends on research volume requirements.